Shadowheart in BG3 offers versatility as a Cleric with savage DPS potential. Armor choices like Luminous Armor and Dark ...

Because of this, you will want to make sure you choose them wisely. Provided you keep Shadowheart as a Cleric, she makes for a great addition to your party. Here are the best Feats for her and for ...

Republican incumbent Nancy Mace leaves the stage on Daniel Island after thanking supporters for sending her to Congress for a third term to represent the 1st Congressional District. Nov. 5, 2024.

CHARLESTON, S.C. (WCBD)- Incumbent U.S. Rep. Nancy Mace (R) cruised to victory in South Carolina’s 1st Congressional District on Tuesday, earning a third term representing the coastal district.

Copyright 2024 The Associated Press. All Rights Reserved. FILE - Rep. Nancy Mace, R-S.C., speaks during the Republican National Convention, July 17, 2024, in ...

SAVANNAH, Ga. (WSAV) – Nancy Mace has been reelected to represent South Carolina’s 1st Congressional District in the U.S. House of Representatives. The district spans much of coastal South ...

COLUMBIA, S.C. (WCSC/AP) — The Palmetto State’s three incumbent representatives to Congress won reelection Tuesday. South Carolina Republican U.S. Rep. Nancy Mace claimed victory in the First ...

Rep. Nancy Mace (R-SC) triumphed over Democrat Michael Moore in South Carolina’s 1st Congressional District, retaining her seat in the House. Mace beat Moore with 58.3% of the vote to Moore’s ...

AP Race Call: Republican Nancy Mace Wins Reelection to U.S. House in South Carolina's 1st Congressional District survived the challenge Copyright 2024 The Associated ...

DANIEL ISLAND — U.S. Rep. Nancy Mace is heading back to Congress for a third term after easily dispatching a Democratic challenger in a race deemed so predictable that she used a two-year-old TV ...

We spoke with Rep. Nancy Mace, the Republican incumbent for the First Congressional District. She is challenged by Democrat Michael B. Moore. Each candidate was asked the same questions.

Treatment with oral semaglutide statistically significantly reduced the risk of MACE by 14% compared with placebo. Topline results were announced from a cardiovascular outcomes study evaluating oral ...